Three decades of responding to infectious disease outbreaksNovember 14, 2017
Soon after his appointment in 1984 as director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, Anthony S. Fauci, M.D., testified before Congress showing a world map annotated with a single emerging infectious disease threat, HIV/AIDS. Since then, diseases and pathogens including chikungunya, H1N1 influenza, severe acute respiratory syndrome (SARS), West Nile, Ebola and Zika viruses were added, providing a powerful visual reminder of the enduring need to anticipate, detect and manage new and emerging infectious diseases around the globe. In an essay in Annals of Internal Medicine published online today, Dr. Fauci reflects on the ways efforts have been marshalled to address infectious disease outbreaks of the past three decades.
Initial responses to a newly recognized disease, now known as HIV/AIDS, in the early 1980s were criticized as being too slow, the essay notes. "The insidious emergence of HIV/AIDS and the lack of due attention by policymakers illustrate how some outbreaks that start subtly can grow to global proportions if they are not aggressively addressed early on," Dr. Fauci writes. Between the early 1980s and the early 1990s, federal funding for HIV/AIDS research increased markedly, reaching $1 billion by the end of 1992. The accelerated government response supported both research and research infrastructure, and yielded advances in countering the HIV/AIDS pandemic domestically and internationally. Ultimately, notes Dr. Fauci, sustained support for scientific research coupled with political and community engagement helped transform HIV/AIDS from a nearly universally fatal disease to a condition that can be managed with appropriate treatment.
In contrast to HIV/AIDS, when outbreaks of respiratory diseases caused by SARS coronavirus and influenza viruses have occurred, they generated immediate widespread public attention and prompted concerted responses by presidential administrations and Congress. For example, the 2009 influenza pandemic began in April and an experimental vaccine entered clinical trials by August. However, despite intense efforts to test and manufacture the new vaccine, adequate supplies to protect the broad U.S. population were not available until early winter, after the outbreak had peaked. "This experience," writes Dr. Fauci, "served as a striking reminder of the inadequacy of our pandemic preparedness capabilities and underscored the need, now being actively pursued, to develop platform technologies that can be applied rapidly to develop vaccines for evolving outbreaks."
The essay also considers how presidential administrations have responded to the appearance of pathogens ranging from West Nile virus and Ebola to, most recently, the arrival of Zika virus in the Americas. "Leadership at the NIAID has learned many valuable lessons through experiences during the prior administrations with regard to optimal responses to such outbreaks," Dr. Fauci concludes. "It is critical to apply these lessons to the infectious disease threats that we will inevitably face in the current administration and beyond."
CI Paules, et al. What recent history has taught us about responding to emerging infectious disease threats. Annals of Internal Medicine DOI: 10.7326/M17-2496 (2017).
NIAID Director Anthony S. Fauci, M.D., is available to discuss his paper.
To schedule interviews, please contact Anne A. Oplinger, 301-402-1663, email@example.com.
NIAID conducts and supports research -- at NIH, throughout the United States, and worldwide--to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health®
NIH/National Institute of Allergy and Infectious Diseases
Related Influenza Articles:
An influenza infection in birds gives a good protection against other subtypes of the virus, like a natural vaccination, according to a new study.
Notre Dame Researchers have discovered a way to make influenza visible to the naked eye, by engineering dye molecules to target a specific enzyme of the virus.
How long does the protection from a mother's immunization against influenza during pregnancy last for infants after they are born?
Whilst countries in the tropics and subtropics exhibit diverse patterns of seasonal flu activity, they can be grouped into eight geographical zones to optimise vaccine formulation and delivery timing, according to a study published April 27, 2016 in the open-access journal PLOS ONE.
Influenza is able to mask itself, so that the virus is not initially detected by our immune system.
Team of scientists from the Icahn School of Medicine at Mount Sinai and Sanford Burnham Prebys Medical Discovery Institute among those who combined large genomic and proteomic datasets to identify novel host targets to treat flu.
Influenza pandemics are potentially the most serious natural catastrophes that affect the human population.
Lack of appropriate drugs and vaccines during the influenza A virus pandemic in 2009, the recent Ebola epidemic in West Africa, as well as the ongoing Middle Eastern Respiratory Syndrome-Coronavirus outbreak demonstrates that the world is only insufficiently prepared for global attacks of emerging infectious diseases and that the handling of such threats remains a great challenge.
In a new bioinformatics analysis of the H7N9 influenza virus that has recently infected humans in China, researchers trace the separate phylogenetic histories of the virus's genes, giving a frightening new picture of viruses where the genes are traveling independently in the environment, across large geographic distances and between species, to form 'a new constellation of genes -- a new disease, based not only on H7, but other strains of influenza.'
Influenza infection can enhance the ability of the bacterium Streptococcus pneumoniae to cause ear and throat infections, according to research published ahead of print in the journal Infection and Immunity.
Related Influenza Reading:
The Great Influenza: The Story of the Deadliest Pandemic in History
by John M. Barry (Author)
The Great Influenza: The Story of the Deadliest Pandemic in History View Details
Very, Very, Very Dreadful: The Influenza Pandemic of 1918
by Albert Marrin (Author)
From National Book Award finalist Albert Marrin comes a fascinating look at the history and science of the deadly 1918 flu pandemic--and the chances for another worldwide pandemic.
In spring of 1918, World War I was underway, and troops at Fort Riley, Kansas, found themselves felled by influenza. By the summer of 1918, the second wave struck as a highly contagious and lethal epidemic and within weeks exploded into a pandemic, an illness that travels rapidly from one continent to another. It would impact the course of the war, and kill many millions more soldiers than warfare... View Details
Influenza: The Hundred Year Hunt to Cure the Deadliest Disease in History
by Dr Jeremy Brown (Author)
On the 100th anniversary of the devastating pandemic of 1918, Jeremy Brown, a veteran ER doctor, explores the troubling, terrifying, and complex history of the flu virus, from the origins of the Great Flu that killed millions, to vexing questions such as: are we prepared for the next epidemic, should you get a flu shot, and how close are we to finding a cure?
While influenza is now often thought of as a common and mild disease, it still kills over 30,000 people in the US each year. Dr. Jeremy Brown, currently Director of Emergency Care Research at the National Institutes of Health,... View Details
Influenza: A Century of Science and Public Health Response
by George Dehner (Author)
In 1976, the outbreak of a new strain of swine flu at the Fort Dix, New Jersey, army base prompted an unprecedented inoculation campaign. Some forty-two million Americans were vaccinated as the National Influenza Immunization Program hastened to prevent a pandemic, while the World Health Organization (WHO) took a wait-and-see approach. Fortunately, the virus did not spread, and only one death occurred. But instead of being lauded, American actions were subsequently denounced as a “fiasco” and instigator of mass panic.
In Influenza, George Dehner examines the wide... View Details
Flu: The Story Of The Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It
by Gina Kolata (Author)
Flu: The Story Of The Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It View Details
America's Forgotten Pandemic: The Influenza of 1918
by Alfred W. Crosby (Author)
Between August 1918 and March 1919 the Spanish influenza spread worldwide, claiming over 25 million lives, more people than those perished in the fighting of the First World War. It proved fatal to at least a half-million Americans. Yet, the Spanish flu pandemic is largely forgotten today. In this vivid narrative, Alfred W. Crosby recounts the course of the pandemic during the panic-stricken months of 1918 and 1919, measures its impact on American society, and probes the curious loss of national memory of this cataclysmic event. In a new edition, with a new preface discussing the recent... View Details
The Influenza Pandemic of 1918-1919 (The Bedford Series in History and Culture)
by Susan K. Kent (Author)
The influenza pandemic of 1918-19 appeared suddenly at the end of the First World War and with explosive impact took the lives of at least 30 million people worldwide. Spreading rapidly across the globe, it defied all previous understandings of the disease, striking the youngest and healthiest individuals most acutely and confounding the doctors and governments who struggled to contain it. In this volume, Susan Kingsley Kent presents an overview of the disease, detailing its symptoms, tracking its spread, and offering insights into the medical community's understanding of and reaction to the... View Details
The Great Influenza: The Epic Story of the Deadliest Plague in History
by John M. Barry (Author)
Textbook of Influenza
by Robert G. Webster (Author), Arnold S. Monto (Author), Thomas J. Braciale (Author), Robert A. Lamb (Author)
The Textbook of Influenza is a comprehensive resource covering all aspects of influenza, from the genetic and molecular biology of the virus through to clinical aspects of the disease and the latest drug developments and treatments. This new edition has been completely revised and reflects the integration of disciplines concerning the emergence, evolution, pathogenesis and control of influenza viruses in the field of human and veterinary public health.
Textbook of Influenza examines the lessons learnt from the latest pandemic and provides the current state of knowledge... View Details
Influenza (Deadly Diseases and Epidemics)
by Donald Emmeluth (Author), Hilary, M.D. Babcock (Editor)
A continuing series with sidebars, further readings, and web site addresses explores different diseases found throughout the world to show the science behind how disease-causing organisms affect the body. View Details